FDA Approves ACETAMINOPHEN AND CODEINE PHOSPHATE — PAI Holdings, LLC dba PAI Pharma

PAI Holdings, LLC dba PAI Pharma secured FDA approval for its Acetaminophen and Codeine Phosphate oral generic, strengthening the company’s position in the prescription pain management market. This approval is anticipated to expand the manufacturer’s product portfolio and heighten competition within the opioid analgesic sector.